Hepatitis C virus lookback: emerging science and public policy

被引：5

作者：

Epstein, J ^{[1
]}

机构：

[1] US FDA, Off Blood Res & Review, Ctr Biol Evaluat & Res, Dept Hlth & Human Serv, Rockville, MD 20852 USA

来源：

TRANSFUSION | 2000年 / 40卷 / 01期

关键词：

D O I：

10.1046/j.1537-2995.2000.40010003.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：3 / 5

页数：3

共 9 条

[1] The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 [J].

Alter, MJ ;

Kruszon-Moran, D ;

Nainan, OV ;

McQuillan, GM ;

Gao, FX ;

Moyer, LA ;

Kaslow, RA ;

Margolis, HS .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (08) :556-562

[2]

[Anonymous], 1998, Fed Regist, V63, P56198

[3] Use of third-generation hepatitis C virus (HCV) enzyme immunoassay (EIA) to resolve second-generation HCV EIA-reactive and second-generation recombinant immunoblot assay-indeterminate blood samples: data to support current Food and Drug Administration guidance on HCV lookback [J].

Busch, MP ;

Tobler, LH ;

Tegtmeier, G ;

Polito, A ;

Quan, S ;

Hirschler, NV ;

Dockter, J ;

Giachetti, C ;

Mimms, L .

TRANSFUSION, 2000, 40 (01) :10-14

[4]

*COMM GOV REF OV, 1996, 104 C 2 SESS HOUS RE, P104

[5]

*CTR BIOL EV RES, BLOOD ACT

[6] Medical progress - Transfusion medicine (First of two parts) - Blood transfusion [J].

Goodnough, LT ;

Brecher, ME ;

Kanter, MH ;

AuBuchon, JP .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (06) :438-447

[7] Lookback on donors who are repeatedly reactive on first-generation hepatitis C virus assays: justification and rational implementation [J].

Tobler, LH ;

Tegtmeier, G ;

Stramer, SL ;

Quan, S ;

Dockter, J ;

Giachetti, C ;

Busch, MP .

TRANSFUSION, 2000, 40 (01) :15-24

[8]

1999, FED REG, V64, P33309

[9]

1998, FED REG, V63, P13675

← 1 →